Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion type Assertion NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_head.
- NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion description "[A daily subcutaneous infusion of 18-base, fully phosporothioated antisense oligonucleotide was administered for 2 weeks to nine patients who had BCL-2-positive relapsed non-Hodgkin lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_provenance.
- NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion evidence source_evidence_literature NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_provenance.
- NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion SIO_000772 9113013 NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_provenance.
- NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion wasDerivedFrom befree-20140225 NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_provenance.
- NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_assertion wasGeneratedBy ECO_0000203 NP893708.RAN5HfhGfUg8HCwdM8en58hFJUOCi5_nt4-3P1PCo790Q130_provenance.